The Company develops and operates outpatient kidney dialysis centers that provide quality dialysis and ancillary services to patients suffering from chronic kidney failure.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Dialysis is a great business with a growing customer base and inevitably recurring revenue. This company is one of the best players in this area. Great mgmt team driving strong revenue and profit growth. They appear to have an intelligent expansion plan that is being well executed. I have been waiting for an opportunity to get into this stock once prices pulled back from an IBD driven pump/dump last year.